Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
出版年份 2016 全文链接
标题
Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
作者
关键词
Effectiveness, HbA1c, Hypoglycemia, Liraglutide, Literature review, Real-world evidence, Safety, Type 2 diabetes, Weight
出版物
Diabetes Therapy
Volume 7, Issue 3, Pages 411-438
出版商
Springer Nature
发表日期
2016-06-27
DOI
10.1007/s13300-016-0180-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial
- (2016) Yutaka Seino et al. Journal of Diabetes Investigation
- Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study
- (2015) Erin K. Buysman et al. ADVANCES IN THERAPY
- Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study
- (2015) Jean-Francois Gautier et al. ADVANCES IN THERAPY
- Correlation Between Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in Italy
- (2015) Annunziata Lapolla et al. CLINICAL THERAPEUTICS
- Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
- (2015) Eusebio Chiefari et al. Diabetes Technology & Therapeutics
- Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes
- (2015) Reimar W. Thomsen et al. DIABETOLOGIA
- Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort study
- (2015) Yoshinobu Kondo et al. ENDOCRINE JOURNAL
- An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes
- (2015) Fernando Gomez-Peralta et al. BMC Endocrine Disorders
- Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallel-group trial
- (2015) Kohei Kaku et al. Journal of Diabetes Investigation
- Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
- (2015) Hideaki Jinnouchi et al. Journal of Diabetes Research
- Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case–control study
- (2015) M. Rigato et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study
- (2015) Pedro Mezquita-Raya et al. Diabetes Therapy
- Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study
- (2015) Pedro Mezquita-Raya et al. Diabetes Therapy
- Clinical efficacy of bariatric surgery versus liraglutide in patients with type 2 diabetes and severe obesity: a 12-month retrospective evaluation
- (2014) M. Cotugno et al. ACTA DIABETOLOGICA
- Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide
- (2014) Mitch DeKoven et al. ADVANCES IN THERAPY
- Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study
- (2014) Abhishek S. Chitnis et al. ADVANCES IN THERAPY
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
- (2014) Manfredi Rizzo et al. Cardiovascular Diabetology
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Predictors of response to liraglutide in Japanese type 2 diabetes
- (2014) Masao Toyoda et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: A prospective study
- (2014) Gonzalo Díaz-Soto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in UK primary care
- (2014) M. E. Nyeland et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
- (2014) Kana Inoue et al. Diabetology & Metabolic Syndrome
- Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients
- (2014) G. T. Russo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
- (2014) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Efficacy of Liraglutide in a Real-Life Cohort
- (2014) Anthony Heymann et al. Diabetes Therapy
- Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
- (2014) Qian Li et al. Diabetes Therapy
- Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients
- (2013) Gian Paolo Fadini et al. ACTA DIABETOLOGICA
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs
- (2013) D. Funch et al. DIABETES OBESITY & METABOLISM
- The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study
- (2013) K. Y. Thong et al. DIABETIC MEDICINE
- Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control
- (2013) Helena Rodbard et al. Endocrine Practice
- Real Life Effects of Liraglutide Supports Those Shown in RCTs
- (2013) A. Karasik et al. VALUE IN HEALTH
- Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function
- (2013) Ryota Usui et al. Journal of Diabetes Investigation
- Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes
- (2013) Yoshinobu Kondo et al. Journal of Diabetes Investigation
- A Retrospective Audit of Type 2 Diabetes Patients Prescribed Liraglutide in Real-Life Clinical Practice
- (2013) Ciara M. Mulligan et al. Diabetes Therapy
- Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes: A randomized, open-label trial
- (2012) R. E. Pratley et al. DIABETES CARE
- Standards of Medical Care in Diabetes--2013
- (2012) DIABETES CARE
- Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study
- (2012) T. Ahern et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
- (2012) Takamasa Ohki et al. TheScientificWorldJOURNAL
- A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice
- (2012) Marc Evans et al. Diabetes Therapy
- Liraglutide Narrows the Range of Circadian Glycemic Variations in Japanese Type 2 Diabetes Patients and Nearly Flattens These Variations in Drug-Naive Type 2 Diabetes Patients: A Continuous Glucose Monitoring–Based Study
- (2011) Yutaka Mori et al. Diabetes Technology & Therapeutics
- Clinical Use of Liraglutide in Type 2 Diabetes and its Effects on Cardiovascular Risk Factors
- (2011) Ajay Varanasi et al. Endocrine Practice
- One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial
- (2011) R. Pratley et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
- (2010) J. B. Buse et al. DIABETES CARE
- Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes
- (2010) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
- (2010) Richard E Pratley et al. LANCET
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
- (2008) M. Nauck et al. DIABETES CARE
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
- (2008) Alan Garber et al. LANCET
- Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
- (2008) W Todd Cade PHYSICAL THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now